HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Undervaccination with diphtheria, tetanus, and pertussis vaccine: National trends and association with pertussis risk in young children.

AbstractBACKGROUND:
The high coverage for ≥3 pertussis vaccine doses among Taiwanese children might not imply timely vaccination. Recently, resurgence of pertussis and challenges with availability of DTaP-IPV-Hib prompted this study.
METHODS:
In the 1996-2012 national birth cohort, we calculated the prevalence and days of undervaccination against pertussis by age 36 months. We also compared the odds of undervaccination in each laboratory-confirmed pertussis patient at ages 3-35 months with sex-, residence-, and age-matched controls from the general population, using conditional logistic regression.
RESULTS:
The prevalence of undervaccination was 60.6% (median 16 days) and decreasing (p < 0.0001). Among 145 cases and 2,900 controls, 58 (40.0%) and 721 (24.9%) were undervaccinated (OR 2.28, 95% CI 1.57-3.31). The attributable risk percent was 22.5% (95% CI 14.5-27.9).
CONCLUSIONS:
Undervaccination was decreasing. Approximately up to one-fifth pertussis cases in children aged 3-35 months could have been prevented with on-time vaccination.
AuthorsWan-Ting Huang, Hui-Chen Lin, Chin-Hui Yang
JournalHuman vaccines & immunotherapeutics (Hum Vaccin Immunother) Vol. 13 Issue 4 Pg. 757-761 (04 03 2017) ISSN: 2164-554X [Electronic] United States
PMID27858500 (Publication Type: Journal Article)
Chemical References
  • Diphtheria-Tetanus-acellular Pertussis Vaccines
Topics
  • Child, Preschool
  • Diphtheria-Tetanus-acellular Pertussis Vaccines (administration & dosage, immunology)
  • Female
  • Humans
  • Immunization (statistics & numerical data)
  • Infant
  • Infant, Newborn
  • Male
  • Retrospective Studies
  • Risk Factors
  • Taiwan (epidemiology)
  • Whooping Cough (epidemiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: